β³ Fetching live dividend data...
Home βΊ Calculator βΊ EKTAF Dividend Calculator 2026
Elekta AB (publ) Β· OTC
Price: $5.25 Β· Annual div: $0.26/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in EKTAF β $142.1K in 10 years Β· $1,312.18/month
Elekta AB (publ) is a global medical technology enterprise providing advanced clinical tools for the treatment of cancer and neurological conditions. Their extensive product portfolio includes leading solutions for radiotherapy, such as Versa HD for brain metastases, the innovative Elekta Unity MR-Linac, Elekta Harmony linear accelerator, and systems like Elekta Infinity and Elekta Synergy for diverse radiotherapy needs, including advanced image guidance. They also offer comprehensive treatment management, quality assurance, and motion management technologies. For multidisciplinary cancer care, Elekta provides MOSAIQ Plaza and the Elekta Axis Cloud managed hosting service. In brachytherapy, their offerings range from the image-guided Elekta Studio and mobile CT ImagingRing to specialized applicators like Venezia and Geneva for cervical cancer, supported by the Oncentra Brachy smart tool and Flexitron afterloader. Their renowned Leksell Gamma Knife series β Icon, Perfexion, and Lightning β delivers precise and accelerated radiosurgery for various indications. Additionally, Elekta supplies neurosurgery products, including the Leksell Vantage and Leksell Stereotactic Systems for both intracranial and minimally invasive procedures. Established in 1972, the company maintains its headquarters in Stockholm, Sweden.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open EKTAF position with:
Real after-tax yield depends on where you live and how you hold EKTAF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 4.92% | 2.12% | $492 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 4.18% | 1.38% | $418 / yr |
| πΊπΈ US Taxable (20%) | 20% | 3.94% | 1.14% | $394 / yr |
| π¬π§ UK ISA | 0% | 4.92% | 2.12% | $492 / yr |
| π¬π§ UK Taxable | 8.75% | 4.49% | 1.69% | $449 / yr |
| π¨π¦ TFSA | 0% | 4.92% | 2.12% | $492 / yr |
| π¨π¦ CA Taxable | 25% | 3.69% | 0.89% | $369 / yr |
| π¦πΊ Super (pension) | 15% | 4.18% | 1.38% | $418 / yr |
| π¦πΊ AU Taxable | 30% | 3.44% | 0.64% | $344 / yr |
| π©πͺ DE Taxable | 26.375% | 3.62% | 0.82% | $362 / yr |
| π«π· FR Taxable | 30% | 3.44% | 0.64% | $344 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.26/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
EKTAF pays quarterly β 4 times per year. Next ex-div: TBD.
How EKTAF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EKTAF sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EKTAF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Elekta AB (publ) (EKTAF) is currently trading at $5.25, 64% below its 52-week high. The current dividend yield is 4.92% based on an annual payout of $0.26 per share.
Elekta AB (publ) (EKTAF) is a healthcare stock currently trading at $5.25 with a dividend yield of 4.92%. The company pays an annual dividend of $0.26 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, EKTAF has grown its dividend at a compound annual rate of 31.9%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β